| Politician | Action | Description | Traded |
|---|---|---|---|
| Buy | CISNE GROUP INC CMN | Apr 24, 2026 | |
| Sell | Charles River Laboratories | May 15, 2025 | |
| Sell | Charles River Laboratories | May 12, 2025 | |
| Buy | Charles River Laboratories | May 8, 2025 | |
| Buy | CARRIER GLOBAL CORPORATION C | Apr 23, 2025 | |
| Buy | CHARLES RIVER LABORATORIES I | Apr 15, 2025 | |
| Buy | CHARLES RIVER LABORATORIES I | Apr 9, 2025 | |
| Buy | Charles River Laboratories | Apr 8, 2025 | |
| Buy | CHARLES RIVER LABORATORIES I | Mar 12, 2025 | |
| Buy | CHARLES RIVER LABORATORIES I | Jan 22, 2025 |
This page tracks congressional stock trading activity in Charles River Laboratories International, Inc. (CRL) in the Healthcare sector. Disclosed Capitol has indexed 59 disclosed congressional trades involving CRL. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of May 2026 — Disclosed Capitol has tracked 59 disclosed congressional trades in Charles River Laboratories International, Inc. (CRL) — 23:22 buy-heavy ratio — led by Ro Khanna (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Apr 24, 2026 | Ro Khanna | D | Buy | $15,001 - $50,000 |
| May 15, 2025 | Rob Bresnahan | R | Sale | $1,001 - $15,000 |
| May 12, 2025 | Jefferson Shreve | R | Sale | $15,001 - $50,000 |
| May 8, 2025 | Jefferson Shreve | R | Buy | $15,001 - $50,000 |
| Apr 23, 2025 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| Apr 15, 2025 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| Apr 9, 2025 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| Apr 8, 2025 | Rob Bresnahan | R | Buy | $15,001 - $50,000 |
| Mar 12, 2025 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| Jan 22, 2025 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
Across the 59 disclosed congressional trades in Charles River Laboratories International, Inc. (CRL), members of Congress have reported 23 buys and 22 sells. The average 30-day alpha vs. the S&P 500 is -1.97%.
As of August 2026, Charles River Laboratories International, Inc. has 1,307 federal contract award records on file from USAspending.gov — most recently $207K from the Department of Veterans Affairs on 2026-08-25.
| Award date | Agency | Amount |
|---|---|---|
| 2026-08-25 | Department of Veterans Affairs | $207K |
| 2026-07-20 | Department of Health and Human Services · National Institutes of Health | $303K |
| 2026-06-15 | Department of Health and Human Services · National Institutes of Health | $340K |
| 2026-06-10 | Department of Health and Human Services · National Institutes of Health | $93K |
| 2026-05-14 | Department of Health and Human Services · National Institutes of Health | $3.1M |
| 2026-05-11 | Department of Health and Human Services · National Institutes of Health | $5.0M |
| 2026-04-02 | Department of Defense · Department of the Air Force | $308K |
| 2026-03-17 | Department of Defense · Department of the Navy | $750K |
| 2026-03-13 | Department of Health and Human Services · National Institutes of Health | $2.1M |
| 2026-03-13 | Department of Health and Human Services · National Institutes of Health | $32.7M |
Negative amounts are contract de-obligations. Browse and filter every award on the government contracts page.
For fiscal year 2025, Charles River Laboratories International, Inc. reported revenue of $4.13B and net income of $474.6M, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $1.00B, net income -$1.5M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.